BRPI0510382A - complexo de inclusão e preparação farmacêutica - Google Patents
complexo de inclusão e preparação farmacêuticaInfo
- Publication number
- BRPI0510382A BRPI0510382A BRPI0510382-7A BRPI0510382A BRPI0510382A BR PI0510382 A BRPI0510382 A BR PI0510382A BR PI0510382 A BRPI0510382 A BR PI0510382A BR PI0510382 A BRPI0510382 A BR PI0510382A
- Authority
- BR
- Brazil
- Prior art keywords
- inclusion complex
- inclusion
- benzimidazole derivative
- pharmaceutical preparation
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
COMPLEXO DE INCLUSãO E PREPARAçãO FARMACêUTICA. A presente invenção se refere a um complexo de inclusão contendo um derivado de benzimidazol com excelente estabilidade à armazenagem e um método para sua preparação. Em particular, a presente invenção se refere a um complexo de inclusão contendo um derivado de benzimidazol com aperfeiçoada estabilidade à armazenagem e a um método para sua preparação, em que um complexo de inclusão é fabricado conduzindo uma reação de inclusão combinando um derivado de benzimidazol, ciclodextrina e um polímero solúvel em água em uma solução alcalina aquosa a fim de ser formulado após estabilizar um derivado de benzimidazol instável a ácido.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040030583A KR20050105565A (ko) | 2004-04-30 | 2004-04-30 | 저장안정성이 우수한 벤즈이미다졸 유도체 함유 포접복합체 및 이의 제조방법 |
PCT/KR2005/001214 WO2005110488A1 (en) | 2004-04-30 | 2005-04-27 | Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0510382A true BRPI0510382A (pt) | 2007-12-26 |
Family
ID=35394000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0510382-7A BRPI0510382A (pt) | 2004-04-30 | 2005-04-27 | complexo de inclusão e preparação farmacêutica |
Country Status (11)
Country | Link |
---|---|
US (1) | US20070212408A1 (pt) |
EP (1) | EP1742667A1 (pt) |
JP (1) | JP2007535533A (pt) |
KR (1) | KR20050105565A (pt) |
CN (1) | CN101010104A (pt) |
AU (1) | AU2005243793A1 (pt) |
BR (1) | BRPI0510382A (pt) |
CA (1) | CA2565168A1 (pt) |
MX (1) | MXPA06012569A (pt) |
RU (1) | RU2006142319A (pt) |
WO (1) | WO2005110488A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070069567A (ko) * | 2005-12-28 | 2007-07-03 | 에스케이케미칼주식회사 | 저장안정성이 우수한 s-오메프라졸 함유 포접 복합체 및이의 제조방법 |
US20100099773A1 (en) * | 2006-11-22 | 2010-04-22 | Jae-Sun Kim | Inclusion complex of sibutramine and beta-cyclodextrin |
CN114195733A (zh) * | 2022-01-07 | 2022-03-18 | 华东理工大学 | 一种抑制烯丙苯噻唑异构化的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW224049B (pt) * | 1991-12-31 | 1994-05-21 | Sunkyong Ind Ltd | |
KR960003605B1 (ko) * | 1992-09-24 | 1996-03-20 | 영진약품공업주식회사 | 경구용 오메프라졸 약제의 코어 조성물을 제조하는 방법 |
NZ337592A (en) * | 1997-03-13 | 2001-01-26 | Hexal Ag | Stabilization of acid sensitive benzimidazoles with amino/cyclodextrin combinations |
KR20030041577A (ko) * | 2001-11-20 | 2003-05-27 | 디디에스텍주식회사 | 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물 |
-
2004
- 2004-04-30 KR KR1020040030583A patent/KR20050105565A/ko not_active Application Discontinuation
-
2005
- 2005-04-27 US US11/587,720 patent/US20070212408A1/en not_active Abandoned
- 2005-04-27 MX MXPA06012569A patent/MXPA06012569A/es unknown
- 2005-04-27 BR BRPI0510382-7A patent/BRPI0510382A/pt not_active IP Right Cessation
- 2005-04-27 AU AU2005243793A patent/AU2005243793A1/en not_active Abandoned
- 2005-04-27 JP JP2007510620A patent/JP2007535533A/ja not_active Abandoned
- 2005-04-27 CN CNA2005800194631A patent/CN101010104A/zh active Pending
- 2005-04-27 RU RU2006142319/04A patent/RU2006142319A/ru not_active Application Discontinuation
- 2005-04-27 EP EP05764810A patent/EP1742667A1/en not_active Withdrawn
- 2005-04-27 WO PCT/KR2005/001214 patent/WO2005110488A1/en active Search and Examination
- 2005-04-27 CA CA002565168A patent/CA2565168A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2007535533A (ja) | 2007-12-06 |
CA2565168A1 (en) | 2005-11-24 |
KR20050105565A (ko) | 2005-11-04 |
US20070212408A1 (en) | 2007-09-13 |
EP1742667A1 (en) | 2007-01-17 |
AU2005243793A1 (en) | 2005-11-24 |
WO2005110488A1 (en) | 2005-11-24 |
RU2006142319A (ru) | 2008-06-10 |
MXPA06012569A (es) | 2007-01-26 |
CN101010104A (zh) | 2007-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088461A (es) | Composiciones farmacéuticas que contienen buprenorfina | |
ECSP13012382A (es) | Composiciones sólidas | |
ES2556585T3 (es) | Composiciones que comprenden sulfato de salbutamol | |
UY32761A (es) | Preparaciones termoestables y preparaciones insulinicas estables a las vibraciones | |
CL2009000393A1 (es) | Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular. | |
CL2011002194A1 (es) | Formulacion que comprende anticuerpo en un regulador de histidina-arginina ph 4.5 a 6.5; articulo de manufactura que comprende dicha formulacion; metodo para estabilizar un anticuerpo en una formulacion farmaceutica acuosa. | |
CL2009002073A1 (es) | Composicion farmaceutica solida para la liberacion controlada de un agente activo activo en el tracto gastrointestinal que comprende al menos un agente acido con solubilidad de menos de 0,3 mg/ml en solucion acuosa a un ph alrededor del pka del agente acido, un polimero hidrofilo, un alcanizador; uso en trastornos cardiovasculares. | |
BR112012013847A2 (pt) | novos derivados de indolinona ciclopropano | |
AR063587A1 (es) | Preparcion liquida que comprende pimobendan | |
CL2011000135A1 (es) | Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica. | |
TR201905487T4 (tr) | Plastikleştirici preparatlar. | |
CO6290686A2 (es) | Dabigatrán para la cateterización cardiaca intervencionista percutánea | |
MX2010002341A (es) | Derivados de bencimidazol usados como agonistas del receptor x de farnesoide. | |
CY1115623T1 (el) | Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ | |
ATE514416T1 (de) | Argatrobanformulierung mit einer säure als lösungsvermittler | |
UY31788A (es) | Formulación farmacéutica sólida con liberación retardada | |
RS53586B1 (en) | DERIVATION OF DECISION | |
ES2531516T3 (es) | Uso de escina | |
NZ593787A (en) | Lyophilised dabigatran | |
AR059357A1 (es) | Formulaciones farmaceuticas | |
MY180605A (en) | An aqueous dispersible polymer composition | |
WO2009062874A3 (en) | Benzimidazole derivatives and their use as fxr agonists | |
BRPI0510382A (pt) | complexo de inclusão e preparação farmacêutica | |
CL2012001159A1 (es) | Composicion que comprende un inhibidor de alfa-1-proteinasa (api), y como minimo, un aminoacido; kit que comprende dicha composicion que se utiliza como una composicion farmaceutica adecuada para administracion intravenosa. | |
AR039935A1 (es) | Formulacion farmaceutica de liberacion inmediata |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: B82Y 5/00 (2011.01), A61K 47/69 (2017.01), A61P 1/ |